TNF-α gene polymorphisms in rheumatoid arthritis patients treated with anti-TNF-α agents: Preliminary results;Polimorfismi del gene del TNF-α in pazienti con artrite reumatoide trattati con biologici anti-TNF-α: Risultati preliminari

Reumatismo

Volumn 54, Issue 1, 2002, Pages 19-26

  Fabris, M ^a   Di Poi, E ^a   Sacco, S ^a   Damante, G ^a   Sinigaglia, L ^a   Ferraccioli, G ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Disease susceptibility; Gene; Rheumatoid arthritis; TNF

Indexed keywords

CYCLOSPORIN A; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SEROLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALLELES; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036221151     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Xenobiotics or biological response modifiers? Methotrexate remains the anchor drug for rheumatoid arthritis
2. Methotrexate and emerging therapies
3. TNF-alpha - A pivotal role in rheumatoid arthritis
4. Treatment with a chimeric monoclonal antibody to tumor necrosis factor suppresses disease activity in rheumatoid arthritis: Results of a multicenter randomized, double blind trial
5. Infliximab and methotrexate in the treatment of RA
6. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
7. Updated consensus statement on tumor necrosis factor blocking agents for the treatment of rheumatoid arthritis
8. Anti-TNF-alpha therapy of rheumatoid arthritis: What have we learned?
9. Prognostic factors in rheumatoid arthritis
10. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: A prospective follow-up study of 147 patients
11. Genetic and enviromental factors in the pathogenesis of rheumatoid arthritis
12. Map of the human major histocompatibility complex
13. Polymorphism of the human TNF-α promoter - Random variation or functional diversity?
14. Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis
15. Tumor necrosis factor-α gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease?
16. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis
17. Functional analysis of a new polymorphism in the human TNF alpha gene promoter
18. Effects of a polymorphism in the human tumor necrosis factor-α on trascription activation
19. Functional analysis of a human tumor necrosis factor-α (TNF-α) promoter polymorphism related to joint damage in rheumatoid arthritis
20. Different transcriptional activity and in vitro TNF-α production in psoriatic patients carrying the TNF-α 238A promoter polymorphism
21. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
22. Disease activity in rheumatoid arthritis: Preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research